Antidepressant use and glycemic control. (Q50726991)

18 March 2018

title

Antidepressant use and glycemic control. (English)

1 reference

18 March 2018

author name string

Ramin Mojtabai

series ordinal

1

1 reference

18 March 2018

publication date

20 January 2013

1 reference

18 March 2018

number of pages

11

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

18 March 2018

volume

227

1 reference

18 March 2018

issue

3

1 reference

18 March 2018

page(s)

467-477

1 reference

18 March 2018

Diagnosis and Classification of Diabetes Mellitus

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-2972-5

Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-2972-5

Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-2972-5

Excess burden of type 1 and type 2 diabetes due to psychopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-2972-5

Long-term effects of fluoxetine on glycemic control in obese patients with non-insulin-dependent diabetes mellitus or glucose intolerance: influence on muscle glycogen synthase and insulin receptor kinase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-2972-5

Depressive disorder and incident diabetes mellitus: the effect of characteristics of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-2972-5

Antidepressant use during pregnancy and childhood autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-2972-5

Usefulness of fluoxetine in obese non-insulin-dependent diabetics: a multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-2972-5

Influence of antidepressant use on glycemic control in patients with diabetes mellitus: an open-label comparative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-2972-5

Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-2972-5

Using the Patient Health Questionnaire-9 to measure depression among racially and ethnically diverse primary care patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-2972-5

Use of antidepressant agents and the risk of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-2972-5

Antidepressant drug use and future diabetes risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-2972-5

Antidepressant medication use, weight gain, and risk of type 2 diabetes: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-2972-5

Antidepressant medication use and risk of hyperglycemia and diabetes mellitus: a noncausal association?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-2972-5

No increased incidence of diabetes in antidepressant users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-2972-5

Influence of antidepressants on glycaemic control in patients with diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-2972-5

The PHQ-9: validity of a brief depression severity measure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-2972-5

Elevated depressive symptoms, antidepressant use, and diabetes in a large multiethnic national sample of postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-2972-5

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-2972-5

Increase in antidepressant medication in the US adult population between 1990 and 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-2972-5

Proportion of antidepressants prescribed without a psychiatric diagnosis is growing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-2972-5

Antidepressants and cardiovascular outcomes in patients without known cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-2972-5

Interaction of a selective serotonin reuptake inhibitor with insulin in the control of hepatic glucose uptake in conscious dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-2972-5

National patterns in antidepressant medication treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-2972-5

Use of antidepressant medication and risk of type 2 diabetes: results from three cohorts of US adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-2972-5

Depressive symptoms, antidepressant medication use, and insulin resistance: the PPP-Botnia Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-2972-5

Association between depressive symptoms and metabolic syndrome is not explained by antidepressant medication: results from the PPP-Botnia Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-2972-5

Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-2972-5

Antidepressant medicine use and risk of developing diabetes during the diabetes prevention program and diabetes prevention program outcomes study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-2972-5

Overadjustment bias and unnecessary adjustment in epidemiologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-2972-5

Antidepressants and Body Weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-2972-5

Selective serotonin reuptake inhibitors and other antidepressants and risk of fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-2972-5

Effect of past and concurrent body mass index on prevalence of glucose intolerance and type 2 (non-insulin-dependent) diabetes and on insulin response. The Israel study of glucose intolerance, obesity and hypertension

21 January 2018

1 reference

12 December 2020

Antidepressant use in persons aged 12 and over: United States, 2005-2008

1 reference

12 December 2020

Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial

1 reference

12 December 2020

Fluoxetine increases insulin action in obese nondiabetic and in obese non-insulin-dependent diabetic individuals

1 reference

12 December 2020

Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans.

1 reference

12 December 2020

Obesity, dyslipidemia, and diabetes with selective serotonin reuptake inhibitors: the Hordaland Health Study.

1 reference

12 December 2020

Improved insulin sensitivity in 80 nondiabetic patients with MDD after clinical remission in a double-blind, randomized trial of amitriptyline and paroxetine.

1 reference

12 December 2020

Relationship of physical activity vs body mass index with type 2 diabetes in women

1 reference

12 December 2020

Weight gain and antidepressants

1 reference

12 December 2020

Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy

1 reference

12 December 2020

National patterns in antidepressant treatment by psychiatrists and general medical providers: results from the national comorbidity survey replication.

1 reference

12 December 2020

Diabetes incidence associated with depression and antidepressants in the Melbourne Longitudinal Studies on Healthy Ageing (MELSHA)

1 reference

12 December 2020

10.1007/S00213-013-2972-5

Identifiers

DOI

1 reference

18 March 2018

1 reference

18 March 2018